Stock ACUR ACURA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Acura Pharmaceuticals, Inc.

Equities

ACUR

US00509L8028

Delayed OTC Markets
Other stock markets
 11:39:58 2024-07-09 am EDT 		5-day change 1st Jan Change
0.02 USD -27.27% Intraday chart for Acura Pharmaceuticals, Inc. -27.27% +19,900.00%
Jun. 14 Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding CI
Jun. 04 Acura Pharmaceuticals, Inc. and Acura Pharmaceutical Technologies, Inc Announce Executive Changes CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K
PU
Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K
PU
Acura Pharmaceuticals : New Financial Obligation - Form 8-K
PU
Acura Pharmaceuticals : Termination of Material Agreement - Form 8-K
PU
Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K
PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K
PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K
PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4
PU
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4
PU
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACUR Stock
  4. News Acura Pharmaceuticals, Inc.
  5. Press Releases